Acclaro Medical | $23,000,000 | (May 30, 2025)
FarmQA, Inc | $4,000,000 | (May 30, 2025)
Uplinq | $10,000,000 | (May 30, 2025)
Certified by Founder
Lodge
Latigo Biotherapeutics, Inc.
start up
United States
- Thousand Oaks, CA
- 15/02/2024
- Series A
- $135,000,000
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
- Industry Biotechnology Research
- Website https://latigobio.com/
- LinkedIn https://www.linkedin.com/company/latigobio/
KhiladiPro | $1,000,000 | (May 30, 2025)
LovOn | $850,000 | (May 30, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
CurifyLabs | $7,594,115 | (May 30, 2025)
Outcomes4Me | $21,000,000 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Unbound(US) | $4,000,000 | (May 30, 2025)
Rime Labs | $5,500,000 | (May 30, 2025)
Vima Therapeutics | $60,000,000 | (May 30, 2025)